Table 4 Top candidate genes after applying the prioritization criteria.

From: QTL-mapping in the obese Berlin Fat Mouse identifies additional candidate genes for obesity and fatty liver disease

Gene score

Phenotype

Chr

Positional candidate gene

Type of mutation

P-value

liver

FC liver

(S1/B6N)

12

Liver weight

1

Astn1

Deleterious domain missense, CTCF binds, UTRs, enhancer and promoter variant

0.66493

− 0.03

10

 

1

Sec16b

Deleterious missense, CTCF binds, UTRs, enhancer and promoter variant

0.54953

− 0.01

13

Body weight,

3

Frem2

Deleterious domain missense, CTCF binds, UTRs, enhancer and promoter variant

0.02092

0.12

12

scAT weight,

3

Bbs7

Tolerated domain missense, CTCF binds, UTRs, enhancer and promoter variant

0.01346

− 0.14

12

BMI

3

Noct

Tolerated domain missense, CTCF binds, UTRs, and promoter variant

0.00876

− 0.17

10

Body weight

6

Met

Tolerated domain missense, CTCF binds, UTRs, and enhancer variant

8.20E06

− 0.1

9

 

6

Ica1

CTCF binds, UTRs, enhancer and promoter variant

0.002

− 0.15

16

Liver TG

8

Fto

Tolerated domain missense, stop gained, CTCF binds, UTRs, enhancer and promoter variant

0.01092

− 0.09

13

 

8

Lpcat2

Deleterious domain missense, CTCF binds, UTRs, enhancer and promoter variant

0.22981

− 0.05

  1. Bold indicates differentially expressed in liver after Benjamini–Hochberg correction.
  2. scAT, subcutaneous adipose tissue; TG, triglycerides; BMI, body mass index; Chr, chromosome; FC, fold change.